| Heterocyclic Compound Synthesis and Bioactivity | Lifetime | 37 | US 6 | 99.48 |
| Cancer, Hypoxia, and Metabolism | Lifetime | 90 | US 44 | 99.64 |
| Cancer Mechanisms and Therapy | Lifetime | 26 | US 16 | 99.45 |
| Cancer therapeutics and mechanisms | Lifetime | 51 | US 32 | 99.55 |
| Cancer-related molecular mechanisms research | Lifetime | 220 | US 68 | 99.10 |
| MicroRNA in disease regulation | Lifetime | 202 | US 67 | 99.15 |
| Cancer-related Molecular Pathways | Lifetime | 178 | US 109 | 99.25 |
| Click Chemistry and Applications | Lifetime | 120 | US 56 | 98.94 |
| Lung Cancer Treatments and Mutations | Lifetime | 342 | US 182 | 99.16 |
| Traditional Chinese Medicine Analysis | Lifetime | 68 | US 4 | 98.70 |
| Ginseng Biological Effects and Applications | Lifetime | 58 | US 3 | 98.59 |
| HER2/EGFR in Cancer Research | Lifetime | 173 | US 84 | 99.19 |
| Histone Deacetylase Inhibitors Research | Lifetime | 125 | US 84 | 98.65 |
| Cancer Cells and Metastasis | Lifetime | 275 | US 131 | 98.71 |
| Vitamin D Research Studies | Lifetime | 143 | US 67 | 98.69 |
| Ubiquitin and proteasome pathways | Lifetime | 297 | US 162 | 98.56 |
| Cell death mechanisms and regulation | Lifetime | 163 | US 70 | 98.65 |
| PI3K/AKT/mTOR signaling in cancer | Lifetime | 158 | US 97 | 98.54 |
| Cancer Treatment and Pharmacology | Lifetime | 381 | US 199 | 98.88 |
| Estrogen and related hormone effects | Lifetime | 367 | US 234 | 98.57 |
| Cancer, Lipids, and Metabolism | Lifetime | 387 | US 201 | 98.46 |
| Pharmacological Effects of Natural Compounds | Lifetime | 323 | US 51 | 97.67 |
| Colorectal Cancer Treatments and Studies | Lifetime | 497 | US 214 | 98.50 |
| Cytokine Signaling Pathways and Interactions | Lifetime | 364 | US 166 | 97.99 |
| Natural product bioactivities and synthesis | Lifetime | 532 | US 66 | 97.63 |
| Bioactive Compounds and Antitumor Agents | Lifetime | 271 | US 104 | 96.92 |
| Computational Drug Discovery Methods | Lifetime | 758 | US 284 | 97.04 |
| Nanoparticle-Based Drug Delivery | Lifetime | 585 | US 110 | 97.77 |
| Lung Cancer Research Studies | Lifetime | 682 | US 291 | 97.71 |
| Drug Transport and Resistance Mechanisms | Lifetime | 897 | US 357 | 96.72 |
| Synthesis and Biological Evaluation | Lifetime | 884 | US 224 | 96.17 |
| Advanced Neuroimaging Techniques and Applications | Lifetime | 859 | US 378 | 96.90 |
| Melanoma and MAPK Pathways | Lifetime | 431 | US 224 | 95.80 |
| Quinazolinone synthesis and applications | Lifetime | 387 | US 75 | 93.91 |
| Advanced Breast Cancer Therapies | Lifetime | 552 | US 242 | 95.71 |
| Cancer, Stress, Anesthesia, and Immune Response | Lifetime | 477 | US 215 | 91.96 |
| NF-κB Signaling Pathways | Lifetime | 831 | US 329 | 93.41 |
| NMR spectroscopy and applications | Lifetime | 916 | US 349 | 93.24 |
| Hedgehog Signaling Pathway Studies | Lifetime | 959 | US 439 | 89.87 |
| 14-3-3 protein interactions | Lifetime | 498 | US 201 | 84.55 |
| Natural Compounds in Disease Treatment | Lifetime | 350 | US 36 | 79.30 |
| Cancer therapeutics and mechanisms | 2021-2025 | 12 | US 5 | 98.86 |
| Cancer Treatment and Pharmacology | 2021-2025 | 31 | US 12 | 99.36 |
| HER2/EGFR in Cancer Research | 2021-2025 | 36 | US 15 | 99.31 |
| Cancer-related Molecular Pathways | 2021-2025 | 25 | US 14 | 97.99 |
| Lung Cancer Treatments and Mutations | 2021-2025 | 178 | US 69 | 98.81 |
| Colorectal Cancer Treatments and Studies | 2021-2025 | 116 | US 45 | 98.41 |
| Monoclonal and Polyclonal Antibodies Research | 2021-2025 | 202 | US 74 | 96.21 |
| Drug Transport and Resistance Mechanisms | 2021-2025 | 58 | US 22 | 95.52 |
| Cancer, Hypoxia, and Metabolism | 2021-2025 | 230 | US 61 | 94.26 |
| Traditional Chinese Medicine Analysis | 2021-2025 | 40 | US 2 | 95.10 |
| MicroRNA in disease regulation | 2021-2025 | 529 | US 52 | 94.38 |
| Advanced Breast Cancer Therapies | 2021-2025 | 202 | US 76 | 96.46 |
| Histone Deacetylase Inhibitors Research | 2021-2025 | 143 | US 60 | 92.29 |
| Ubiquitin and proteasome pathways | 2021-2025 | 251 | US 64 | 91.47 |
| Cell death mechanisms and regulation | 2021-2025 | 45 | US 10 | 90.12 |
| Epigenetics and DNA Methylation | 2021-2025 | 923 | US 302 | 90.49 |
| Cytokine Signaling Pathways and Interactions | 2021-2025 | 131 | US 33 | 88.72 |
| Lung Cancer Research Studies | 2021-2025 | 802 | US 241 | 91.35 |
| Cancer Mechanisms and Therapy | 2021-2025 | 249 | US 36 | 87.51 |
| Natural product bioactivities and synthesis | 2021-2025 | 444 | US 14 | 87.56 |
| Peptidase Inhibition and Analysis | 2021-2025 | 719 | US 173 | 88.61 |
| Vitamin D Research Studies | 2021-2025 | 273 | US 47 | 87.28 |
| Cancer, Lipids, and Metabolism | 2021-2025 | 664 | US 131 | 86.94 |
| Cell Adhesion Molecules Research | 2021-2025 | 255 | US 73 | 84.64 |
| Cancer Cells and Metastasis | 2021-2025 | 771 | US 191 | 85.85 |
| Heterocyclic Compound Synthesis and Bioactivity | 2021-2025 | 851 | US 17 | 89.97 |
| Metabolomics and Mass Spectrometry Studies | 2021-2025 | 933 | US 195 | 86.58 |
| Pharmacological Effects of Natural Compounds | 2021-2025 | 535 | US 26 | 84.44 |
| Microtubule and mitosis dynamics | 2021-2025 | 260 | US 90 | 84.71 |
| Melanoma and MAPK Pathways | 2021-2025 | 312 | US 104 | 85.32 |
| Protein Degradation and Inhibitors | 2021-2025 | 913 | US 383 | 85.08 |
| Pharmacogenetics and Drug Metabolism | 2021-2025 | 315 | US 100 | 84.93 |
| Myasthenia Gravis and Thymoma | 2021-2025 | 308 | US 65 | 84.36 |
| Synthesis and Biological Evaluation | 2021-2025 | 646 | US 13 | 80.08 |
| Click Chemistry and Applications | 2021-2025 | 884 | US 99 | 79.63 |
| Intracerebral and Subarachnoid Hemorrhage Research | 2021-2025 | 963 | US 285 | 79.60 |
| PARP inhibition in cancer therapy | 2021-2025 | 969 | US 343 | 77.93 |
| Ginseng Biological Effects and Applications | 2021-2025 | 478 | US 16 | 77.92 |
| Ion Channels and Receptors | 2021-2025 | 273 | US 74 | 76.18 |
| Retinoids in leukemia and cellular processes | 2021-2025 | 403 | US 129 | 68.61 |
| Hippo pathway signaling and YAP/TAZ | 2021-2025 | 477 | US 113 | 66.99 |
| Phytochemical Studies and Bioactivities | 2021-2025 | 189 | US 6 | 66.98 |
| PI3K/AKT/mTOR signaling in cancer | 2021-2025 | 667 | US 236 | 65.71 |
| Quinazolinone synthesis and applications | 2021-2025 | 716 | US 37 | 59.02 |
| NF-κB Signaling Pathways | 2021-2025 | 371 | US 47 | 55.60 |
| Acne and Rosacea Treatments and Effects | 2021-2025 | 945 | US 200 | 56.17 |
| 14-3-3 protein interactions | 2021-2025 | 116 | US 30 | 55.60 |
| Dermatological and Skeletal Disorders | 2021-2025 | 504 | US 138 | 55.18 |
| Bioactive Natural Diterpenoids Research | 2021-2025 | 299 | US 11 | 53.09 |
| Inorganic and Organometallic Chemistry | 2021-2025 | 583 | US 19 | 37.98 |